eNcounterView vs Captisol AR
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
eNcounterView
A video conferencing tool for the medical community, enabling remote consultations and real-time sharing of patient data. It aims to make healthcare more accessible by connecting patients with providers.
- Video conferencing for medical use
- Patient-provider connections
- Real-time medical data sharing
- Remote consultations
- Integrated with eNcounter suite
Read full descriptionHide full description
GlobalMed's eNcounterView is a lightweight video conferencing solution designed specifically for the needs of the medical community. Working as a standalone application or integrated into the eNcounter application suite, eNcouterView is used to connect patients with providers. Enabling real-time sharing of medical data, eNcounterView is supported by RTC technologies to facilitate remote consultations and expand upon GlobalMed's mission of making healthcare accessible to all.
Captisol AR
Read full descriptionHide full description
Captisol is a beta-cyclodextrin with an average of 7 sulfobutylether (SBE) substitutions per molecule that was rationally designed to improve the solubility, stability, bioavailability and dosing of biologically active compounds. Ollomol AR for Captisol was designed to visualize in 3D-AR a number of Captisol-based supramolecular complexes. It allows viewing in an immersive way the movement of the structures at atomic resolution, explicitly considering all the classical degrees of freedom. The movies were generated by Molecular Dynamics simulations using the GROMACS software and the GROMOS force field with a specific parameterization for Captisol (considering a structure with four SBE groups positioned on the C6-OH of alternating glucose rings and three additional SBE groups placed on the C3-OH of the remaining glucose rings of the cyclodextrin).
Screenshots
Verdict
The clearest difference is update cadence: Captisol AR at every 2 months against eNcounterView's every 9 months. eNcounterView's advantage is iOS requirement (11.0 vs 13.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
eNcounterView ships an update every 9 months, Captisol AR every 2 months. The most recent releases landed on November 13, 2026 and November 11, 2026 respectively.
| Parameter | eNcounterView | Captisol AR |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 2 — better | — |
| Update frequency | Every 9 months | Every 2 months — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 11.0 — better | 13.0 |
| Further details — not scored | ||
| Size | 31 MB | 247 MB |
| Age rating | 12+ | 4+ |
| Developer | GlobalMed | MD. USE INNOVATIONS SL |
In-app purchases
eNcounterView
No in-app purchases
Captisol AR
No in-app purchases









